Clinical Trial Manager overseeing global Phase 3 program for cardiovascular drug development. Responsible for regional study and vendor management while collaborating with clinical operations teams.

Braveheart Bio is a late clinical-stage biotechnology company developing novel therapeutics for hypertrophic cardiomyopathy and related conditions.
The company is backed by experienced life science investors including Andreessen Horowitz (a16z Bio + Health), Forbion, OrbiMed, Enavate Sciences (a platform of Patient Square Capital), and Frazier Life Sciences.
Braveheart is advancing BHB-1893 through late-stage clinical development with the goal of establishing a new standard of care.
Browse and apply for open jobs at Braveheart Bio.
Clinical Trial Manager overseeing global Phase 3 program for cardiovascular drug development. Responsible for regional study and vendor management while collaborating with clinical operations teams.
Managing clinical supplies logistics and drug product distribution for biopharmaceutical trials at Braveheart Bio. Collaborate with cross - functional teams to ensure timely supply and compliance.
Director of Regulatory Affairs leading global regulatory strategy for Braveheart Bio’s Phase 3 HCM program. Collaborating with cross - functional teams and ensuring successful regulatory submissions.